Precision medicine shows great potential in helping patients get personalized interventions for many conditions, said Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Precision medicine shows great potential in helping patients get personalized interventions for many conditions, said Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Transcript (slightly modified)
Will precision medicine be present in all disease states eventually, or are there some that won’t benefit from precision medicine?
There’s always going to be things, I think, where it doesn’t matter very much; might be because the agents we use to treat that condition would just be divided into children and adults and pretty much 100% of the children or adults given the right dose will respond. And those things will probably be down the path of time before they become part of the precision medicine initiative.
But there are others, all along the way there, that it will matter greatly to subdivide much more than just, a child gets this dose and an adult gets that dose, in terms of how much medicine somebody should get. There will be differences discovered in how they metabolize those medicines, absorb those medicines, how it impacts receptors in their body driven by their genetics mostly. And then there’ll be patients who don’t respond at all to some things, and will respond to others, and knowing which to use first is really delivering great care with great value, great triple aim.
And understanding that will come out of the precision medicine initiative of researching, do we have the right algorithm to analyze why should this person get a different intervention than that person? Based on their genetics, based on their social milieu, based on their comorbidities, and everything we put into that equation about what makes them unique.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Kathy Oubre on Strategies to Mitigate Challenges When Adopting New Payment Models
February 23rd 2024While adopting new payment models can come with challenges, there are strategies that can help oncology practices optimize their approaches, said Kathy Oubre, MS, CEO of Pontchartrain Cancer Center.
Read More
Getting to Know Dr Shauna Downs, Public Health Nutritionist
February 23rd 2024Shauna Downs, PhD, MS, is an associate professor in the Department of Health Behavior, Society, and Policy at the Rutgers School of Public Health. A former figure skater, her research now focuses on interventions to promote healthy and sustainable food choices and exploring how our changing climate, food systems, diet, and nutrition are inextricably linked.
Read More